JCS/JHRS 2021 guideline focused update on non‐pharmacotherapy of cardiac arrhythmias

Abbreviations A-ATP atrial anti-tachycardia pacing ACC American College of Cardiology ACP advance care planning ACT activated clotting time AF atrial fibrillation AHA American Heart Association AHRE atrial high-rate episodes AVNRT atrioventricular nodal reentrant tachycardia BARC Bleeding Academic Research Consortium CBA cryoballoon ablation CIED cardiac implantable electronic device COR class of recommendation CRT cardiac resynchronization therapy CRT-D cardiac resynchronization therapy defibrillator CRT-P cardiac resynchronization therapy pacemaker CT computed tomography DAP dose–area product DAPT dual antiplatelet therapy DNAR Do Not Attempt Resuscitation DOAC direct oral anticoagulant EBM evidence-based medicine ESC European Society of Cardiology FDA Food and Drug Administration GOR grade of recommendation HF heart failure HFrEF heart failure with reduced ejection fraction HPSD high-power short-duration HRS Heart Rhythm Society ICD implantable cardioverter-defibrillator JCS Japanese Circulation Society JHRS Japanese Heart Rhythm Society LOE level of evidence LVEF left ventricular ejection fraction MRI magnetic resonance imaging MVP minimal ventricular pacing NASPE North American Society of Pacing and Electrophysiology NYHA New York Heart Association QOL quality of life RCT randomized controlled trial RFCA radio-frequency catheter ablation SCAF subclinical atrial fibrillation vHPSD very high-power short-duration Abbreviations of Research Names AATAC Ablation vs Amiodarone for Treatment of Atrial Fibrillation in Patients with Congestive Heart Failure and an Implanted ICD/CRTD ABRIDGE-J Ablation Perioperative Dabigatran in Use Envisioning in Japan ARISTESiA Apixaban for the Reduction of Thrombo-Embolism in Patients with Device-Detected Sub-Clinical Atrial Fibrillation ASSERT Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial ASAP ASA Plavix Feasibility Study with Watchman Left Atrial Appendage Closure Technology ATTEST Atrial Therapy Efficacy and Safety Trial AXAFA AFNET 5 Anticoagulation Using the Direct Factor Xa Inhibitor Apixaban during Atrial Fibrillation Catheter Ablation: Comparison to VKA Therapy CABANA Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients with Atrial Fibrillation CASTLE-AF Catheter Ablation for Atrial Fibrillation with Heart Failure CIRCA-DOSE Study Cryoballoon vs. Novel Anticoagulation